DNA Brands, Inc. (DNAX)

DNA Brands Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	0.01	-	0.06	0.07	-
Cash & Short-Term Investments	0.01	0	0.06	0.07	-
Cash Growth	2821.24%	-99.20%	-10.76%	-	-
Other Current Assets	0.03	-	0.04	0	-
Total Current Assets	0.04	-	0.1	0.07	-
Property, Plant & Equipment	0.01	-	-	-	-
Long-Term Investments	1	-	-	-	-
Total Assets	1.05	-	0.1	0.07	-
Accounts Payable	0.11	-	0.11	0.11	-
Accrued Expenses	-	-	0.4	-	-
Short-Term Debt	0	-	-	-	-
Current Portion of Long-Term Debt	2.13	-	1.94	1.6	-
Other Current Liabilities	0.48	-	0.17	0.17	-
Total Current Liabilities	2.73	-	2.61	1.88	-
Total Liabilities	2.73	-	2.61	1.88	-
Common Stock	5.08	-	5.08	5.08	-
Additional Paid-In Capital	23.36	-	23.63	23.63	-
Retained Earnings	-32.57	-	-31.22	-30.52	-
Total Common Equity	-4.13	-2.74	-2.51	-1.81	-
Shareholders' Equity	-1.67	-2.74	-2.51	-1.81	-
Total Liabilities & Equity	1.05	-	0.1	0.07	-
Total Debt	2.14	2	1.94	1.6	-
Net Cash (Debt)	-2.12	-2	-1.88	-1.53	-
Net Cash Per Share	-0.47	-	-48.15	-51.60	-
Filing Date Shares Outstanding	4.49	-	0.04	0.03	-
Total Common Shares Outstanding	4.49	-	0.04	0.03	-
Working Capital	-2.69	-	-2.51	-1.81	-
Book Value Per Share	-0.92	-3.73	-64.30	-60.86	-
Tangible Book Value	-4.13	-2.74	-2.51	-1.81	-
Tangible Book Value Per Share	-0.92	-3.73	-64.30	-60.86	-

Source: S&P Capital IQ. Standard template. Financial Sources.